These changes are related to the sodium-retaining properties of GH and IGF-1 via ENaC in the renal distal tubules (vide supra) and can be reversed if patients undergo effective treatment of the GH-producing tumor [100]. This evidence concerns the gene IGF1 and neoplasm.